-
-
NeuroX profiling of samples from the PPMI prodromal and genetic cohorts, the LRRK2 cohort consortium and the BioFIND cohort
… Study Rationale: This work aims to provide genetic information at common genetic variants and rare genetic variants that have … aims to produce data that allows researchers to look at how genetic changes are involved in Parkinson disease. It …
-
Michael J. Fox Foundation Commits up to $2 Million to Address "Critical Challenges" in PD
May 24, 2007
… NEWYORK, NY — The Michael J. Fox Foundation today announced the launch of Critical Challenges in PD , … particular topic areas of interest. Critical Challenges , however, differs in that the Foundation is asking … would greatly accelerate drug discovery efforts to identify compounds that can modify LRRK2 kinase activity. …
-
Michael J. Fox Foundation Commits up to $2 Million to Improve Drug Delivery for Parkinson's Disease
March 5, 2008
… NY — The Michael J. Fox Foundation for Parkinson’s Research today announced the launch of a new funding program, … second challenge is the need to more precisely understand how molecules move inside the central nervous system in … not only “small-molecule” therapeutics — the chemical compounds that make up the majority of drugs brought to …
-
Seven Hours and $51,000 Closer to a Cure, Thanks to Team Fox Member Nick Manis
August 12, 2020
… Nick Manis is a competitor at heart. A standout high lacrosse player, the … everything. I just wanted to make a difference somehow and return the positive energy,” says Nick. In February, …
-
A Letter from 'Back to the Future' co-creator Bob Gale
November 25, 2015
… 25, 2015 Dear Friend, As you know, in our 1989 film Back to the Future Part II , director Robert Zemeckis and I made … about the world of 2015, and on October 21st, we got to see how many of them came true. It turns out, we got more right … one.” So please join me in supporting MJFF and Team Fox: Together, we can make a future without Parkinson's disease a …